Provid Pharmaceuticals

Developing MHC inhibition drugs for multiple sclerosis and autoimmune diseases

placeMonmouth Junction, New Jersey, United States calendar_todayFounded 2001 groups5 employees language provid.com

Registered entities

Investor mix

1 investor on record.

Investor typeCountShare
Other / undisclosed1100%
Coming soon